ATE306923T1 - Verwendung von (e)-metanicotinederivate als analgetika - Google Patents

Verwendung von (e)-metanicotinederivate als analgetika

Info

Publication number
ATE306923T1
ATE306923T1 AT98940814T AT98940814T ATE306923T1 AT E306923 T1 ATE306923 T1 AT E306923T1 AT 98940814 T AT98940814 T AT 98940814T AT 98940814 T AT98940814 T AT 98940814T AT E306923 T1 ATE306923 T1 AT E306923T1
Authority
AT
Austria
Prior art keywords
metanicotine
patient
analgesics
derivatives
relates
Prior art date
Application number
AT98940814T
Other languages
English (en)
Inventor
Billy R Martin
Mohamad L Damaj
Original Assignee
Univ Virginia Commonwealth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia Commonwealth filed Critical Univ Virginia Commonwealth
Application granted granted Critical
Publication of ATE306923T1 publication Critical patent/ATE306923T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT98940814T 1997-08-07 1998-08-07 Verwendung von (e)-metanicotinederivate als analgetika ATE306923T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/908,440 US5914337A (en) 1997-08-07 1997-08-07 Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
PCT/US1998/016485 WO1999007369A1 (en) 1997-08-07 1998-08-07 Compounds and pharmaceutical compositions thereof for eliciting analgesic effects

Publications (1)

Publication Number Publication Date
ATE306923T1 true ATE306923T1 (de) 2005-11-15

Family

ID=25425808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940814T ATE306923T1 (de) 1997-08-07 1998-08-07 Verwendung von (e)-metanicotinederivate als analgetika

Country Status (8)

Country Link
US (2) US5914337A (de)
EP (1) EP1011672B1 (de)
AT (1) ATE306923T1 (de)
AU (1) AU8900498A (de)
DE (1) DE69831959T2 (de)
DK (1) DK1011672T3 (de)
ES (1) ES2251779T3 (de)
WO (1) WO1999007369A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1056458T3 (da) * 1998-02-24 2005-08-01 Univ Wake Forest Behandling af kronisk smerte
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
CA2376061A1 (en) * 1999-06-07 2000-12-14 Targacept, Inc. Pharmaceutical compositions and methods for use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds

Also Published As

Publication number Publication date
US6117891A (en) 2000-09-12
EP1011672A1 (de) 2000-06-28
AU8900498A (en) 1999-03-01
WO1999007369A1 (en) 1999-02-18
DE69831959T2 (de) 2006-07-27
EP1011672A4 (de) 2001-04-04
US5914337A (en) 1999-06-22
DE69831959D1 (de) 2006-03-02
ES2251779T3 (es) 2006-05-01
DK1011672T3 (da) 2006-02-06
EP1011672B1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
EA199800667A1 (ru) Новые фенантридины
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
SE0104248D0 (sv) Method of treatment
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
ATE209920T1 (de) Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
EA199800866A1 (ru) Способ снятия боли
ATE345117T1 (de) Biphenylverbindungen sowie ihre anwendung als östrogene mittel
ATE306923T1 (de) Verwendung von (e)-metanicotinederivate als analgetika
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
DE69924979D1 (de) Behandlung von chronischen schmerzen
EA199800535A1 (ru) Способ лечения боли
BR9906803A (pt) Processo para tratamento de copd
EA199900174A1 (ru) Способ лечения биполярного расстройства
ATE334982T1 (de) 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-
ATE306269T1 (de) Behandlung der exzessiven aggressivität mit olanzapine
NO995132L (no) Fremgangsmåte for reduksjon av fibrinogen
ATE293605T1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011672

Country of ref document: EP

REN Ceased due to non-payment of the annual fee